Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiangping Song

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
BMC Medicine|January 7, 2024
Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathyMengxia Fu, Xiumeng Hua, Songren Shu, et al.
Circulation|January 24, 2022
Multifaceted Spatial and Functional Zonation of Cardiac Cells in Adult Human HeartLiang Chen, Kui Hua, Ningning Zhang, et al.
BMC Medicine|April 13, 2025
Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathyHao Cui, Songren Shu, Ningning Zhang, et al.
BMC Medicine|October 19, 2023
Tomo-seq identifies NINJ1 as a potential target for anti-inflammatory strategy in thoracic aortic dissectionYixuan Sheng, Liying Wu, Yuan Chang, et al.
Cellular & Molecular Immunology|January 5, 2022
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophagesZhenfeng Wang, Jiadi Lv, Pin Yu, et al.
Journal of Advanced Research|September 18, 2023
Deciphering mechanisms of cardiomyocytes and non-cardiomyocyte transformation in myocardial remodeling of permanent atrial fibrillationYixuan Sheng, Yin-Ying Wang, Yuan Chang, et al.
Cardiovascular Research|September 13, 2024
Abnormal circadian rhythms exacerbate dilated cardiomyopathy by reducing the ventricular mechanical strengthHao Jia, Hao Cui, Zijie Zhao, et al.
European Heart Journal|June 28, 2021
Neuraminidase 1 is a driver of experimental cardiac hypertrophyQian-Qian Chen, Gaoxiang Ma, Jin-Feng Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
AAV9-mediated gene supplementation therapy prevents and rescues arrhythmogenic cardiomyopathy in Pnpla2-mutated miceXiulin Zhang, Congrui Wang, Yuan Chang, et al.
Theranostics|December 8, 2025
Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditisXiumeng Hua, Zhe Sun, Ziwei Liang, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
BMC Medicine|January 7, 2024
Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathyMengxia Fu, Xiumeng Hua, Songren Shu, et al.
Circulation|January 24, 2022
Multifaceted Spatial and Functional Zonation of Cardiac Cells in Adult Human HeartLiang Chen, Kui Hua, Ningning Zhang, et al.
BMC Medicine|April 13, 2025
Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathyHao Cui, Songren Shu, Ningning Zhang, et al.
BMC Medicine|October 19, 2023
Tomo-seq identifies NINJ1 as a potential target for anti-inflammatory strategy in thoracic aortic dissectionYixuan Sheng, Liying Wu, Yuan Chang, et al.
Cellular & Molecular Immunology|January 5, 2022
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophagesZhenfeng Wang, Jiadi Lv, Pin Yu, et al.
Journal of Advanced Research|September 18, 2023
Deciphering mechanisms of cardiomyocytes and non-cardiomyocyte transformation in myocardial remodeling of permanent atrial fibrillationYixuan Sheng, Yin-Ying Wang, Yuan Chang, et al.
Cardiovascular Research|September 13, 2024
Abnormal circadian rhythms exacerbate dilated cardiomyopathy by reducing the ventricular mechanical strengthHao Jia, Hao Cui, Zijie Zhao, et al.
European Heart Journal|June 28, 2021
Neuraminidase 1 is a driver of experimental cardiac hypertrophyQian-Qian Chen, Gaoxiang Ma, Jin-Feng Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
AAV9-mediated gene supplementation therapy prevents and rescues arrhythmogenic cardiomyopathy in Pnpla2-mutated miceXiulin Zhang, Congrui Wang, Yuan Chang, et al.
Theranostics|December 8, 2025
Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditisXiumeng Hua, Zhe Sun, Ziwei Liang, et al.
Pageof 23